Cargando…
A Pex7 Deficient Mouse Series Correlates Biochemical and Neurobehavioral Markers to Genotype Severity—Implications for the Disease Spectrum of Rhizomelic Chondrodysplasia Punctata Type 1
Rhizomelic chondrodysplasia punctata type 1 (RCDP1) is a peroxisome biogenesis disorder caused by defects in PEX7 leading to impairment in plasmalogen (Pls) biosynthesis and phytanic acid (PA) oxidation. Pls deficiency is the main pathogenic factor that determines the severity of RCDP. Severe (class...
Autores principales: | Fallatah, Wedad, Cui, Wei, Di Pietro, Erminia, Carter, Grace T., Pounder, Brittany, Dorninger, Fabian, Pifl, Christian, Moser, Ann B., Berger, Johannes, Braverman, Nancy E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310236/ https://www.ncbi.nlm.nih.gov/pubmed/35898397 http://dx.doi.org/10.3389/fcell.2022.886316 |
Ejemplares similares
-
Rhizomelic Chondrodysplasia Punctata Type 1 Caused by a Novel Mutation in the PEX7 Gene
por: Çim, Abdullah, et al.
Publicado: (2015) -
The neurology of rhizomelic chondrodysplasia punctata
por: Bams-Mengerink, Annemieke M, et al.
Publicado: (2013) -
Rare Case of Rhizomelic Chondrodysplasia Punctata
por: Mahale, Yashwant, et al.
Publicado: (2015) -
Oral administration of a synthetic vinyl-ether plasmalogen normalizes open field activity in a mouse model of rhizomelic chondrodysplasia punctata
por: Fallatah, Wedad, et al.
Publicado: (2020) -
A Case of Rhizomelic Chondrodysplasia Punctata in Newborn
por: Karabayır, Nalan, et al.
Publicado: (2014)